Therapeutic Goods Administration
-
New treatment options approved
The Castlemaine chapter of Mind Medicine Australia is celebrating the recent announcement that the Therapeutic Goods Administration will reschedule the medical use of MDMA and psilocybin from July 1. The rescheduling will enable authorised psychiatrists to prescribe these psychedelic substances for treatment-resistant depression and treatment-resistant post-traumatic stress disorder. All other uses of MDMA and Psilocybin…